Go to content
UR Home

N-acetylcysteine in the prevention of radiocontrast-induced nephropathy: clinical trials and end points

DOI to cite this document:
Hoffmann, Ute ; Banas, Bernhard ; Fischereder, Michael ; Krämer, Bernhard K.
(140kB) - Repository staff only
Date of publication of this fulltext: 05 Aug 2009 13:27


N-acetylcysteine (NAC) has been suggested to prevent radiocontrast-induced nephropathy (RCIN) in patients with a reduced renal function. However, clinical studies have not been demonstrating this effect consistently. Also, reviews and meta-analyses dealing with the question of prevention of RCIN by NAC have been controversial. Nearly all investigators used serum creatinine as surrogate end point ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons